Laying the Foundation for Real-World Evidence Studies of Psoriatic Disease in Newfoundland and Labrador

The Janssen and Newfoundland and Labrador Health Innovation Partnership (JANL-HIP) was established to carry out Real-World Evidence (RWE) projects to generate evidence about disease pathways, healthcare delivery, the effects of clinical interventions. Doing so will support and influence clinical dec...

Full description

Bibliographic Details
Published in:International Journal of Population Data Science
Main Authors: Winifred Badaiki, Evelyn Pyper, Kendra Lester, Janelle Skeard, Michelle Penney, Janey Shin, Brenda Fisher, Huong Hew, Susanne Gulliver, Wayne Gulliver, Proton Rahman
Format: Article in Journal/Newspaper
Language:English
Published: Swansea University 2022
Subjects:
Real world data
psoriasis
real world evidence
research partnership
Newfoundland and Labrador
Demography. Population. Vital events
HB848-3697
Newfoundland
Online Access:https://doi.org/10.23889/ijpds.v7i1.1690
https://doaj.org/article/b822f14c00d44ed382be84d8483b3a57
Description
Summary:The Janssen and Newfoundland and Labrador Health Innovation Partnership (JANL-HIP) was established to carry out Real-World Evidence (RWE) projects to generate evidence about disease pathways, healthcare delivery, the effects of clinical interventions. Doing so will support and influence clinical decision-making in Newfoundland and Labrador (NL). This case study describes the foundational elements necessary for a~real-world evidence~generation project in NL and may provide learning for the effective execution of real-world studies in other jurisdictions. It uses an ongoing project in psoriatic disease in NL to illustrate the partnership and the benefits of RWE studies. Ultimately, the JANL-HIP RWE project aims to inform decisions that will drive improvements in health outcomes, system delivery, and policy mutually beneficial to health ecosystem stakeholders.

Similar Items